Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Minnesota
About this trial
This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pregnant individuals aged 18 years or older
Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound
Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12)
Ability to understand and read English
Disqualifiers
Severe nausea and vomiting, defined as a PUQE score >12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy
Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD)
History of severe anxiety disorders affecting breathing patterns
Known deviated nasal septum
Trial design
Design model
Parallel
Treatments tested in this trial
Alternate Nostril Breathing
BehavioralANB 3 times per day for 5-10 minutes per session over a 7-day period
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Alternate Nostril BreathingActive comparator 1 intervention
Group B: Usual Care OnlyNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Severity of Nausea and Vomiting
Measured by the change in the Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score, where scores range from 3-15, and a higher score indicates greater severity of nausea and vomiting.
Time frame
Day 7Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov